IL6 and COVID-19: An investigation with 33 diagnosed patients with COVID-19 in comparison with COVID-19-negative individuals demonstrated that altered metabolite levels of the fatty acid and tryptophan metabolism in infected patients were correlated with clinical markers of inflammation (IL-6 and C-reactive protein) and renal function (BUN and creatinine; Thomas et al., 2020).